Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

RBMX functional retrocopy safeguards brain development in a species-dependent context.

Brain : a journal of neurology·2026
Same author

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

De novo variants in LDB1 are linked to distinct neurodevelopmental phenotypes determined by variant location and differing pathomechanisms.

American journal of human genetics·2026
Same author

Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizures.

The Journal of clinical investigation·2026
Same author

Distinct Brain Drivers and Shared Cerebello-Cortical Input in ADCY5 and SGCE Hyperkinetic Movements.

Movement disorders : official journal of the Movement Disorder Society·2026

Related Experiment Video

Updated: Dec 23, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.2K

Increased diagnostic yield in complex dystonia through exome sequencing.

Thomas Wirth1, Christine Tranchant2, Nathalie Drouot3

  • 1Département de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Unit of Functional Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.

Parkinsonism & Related Disorders
|April 26, 2020
PubMed
Summary
This summary is machine-generated.

Whole Exome Sequencing (WES) significantly improves diagnosing genetic causes of dystonia, identifying new variants in over a third of patients unresponsive to gene panels. This approach is particularly effective for complex dystonia cases.

Keywords:
DystoniaExomeGenetic diagnosisNext generation sequencingPhenotype

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.9K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.1K

Related Experiment Videos

Last Updated: Dec 23, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.2K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.9K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.1K

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Targeted gene panel sequencing identifies pathogenic variants in less than 20% of early-onset and familial dystonia cases.
  • Many dystonia patients remain undiagnosed despite comprehensive genetic testing.

Purpose of the Study:

  • To identify genetic causes of dystonia in patients who were undiagnosed after gene panel sequencing.
  • To evaluate the diagnostic utility of Whole Exome Sequencing (WES) in these cases.

Main Methods:

  • Whole Exome Sequencing (WES) was performed on DNA from 32 patients with early-onset or familial dystonia.
  • Patient data included family history, dystonia presentation, and associated symptoms.

Main Results:

  • Causative variants were identified in 11 patients (34.4% diagnostic rate) across 9 genes.
  • Diagnostic yield was significantly higher in complex dystonia (66.7%) and in patients with intellectual disability (87.5%).

Conclusions:

  • Whole Exome Sequencing (WES) is an effective tool for increasing diagnostic yield in dystonia after gene panel sequencing.
  • Further research is needed to explore the genetic overlap between neurodevelopmental disorders and dystonia.